Atlas Trials

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

Clinical trial NCT00304993 · COMPLETED

Trial details

NCT number
NCT00304993
Sponsor
Foundation Research, Florida
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Metabolic Syndrome XInsulin Resistance
Start date
2001-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.